Concepedia

Adrian Kielhorn

AK

Statistics

Publications

17

Citations

627

H-Index

15

Active since

1996

Affiliations

Amgen (United States)(Current)

Massachusetts General Hospital

Alexion Pharmaceuticals (United States)

Harvard University

GlaxoSmithKline (Germany)

Adrian Kielhorn is an author at Amgen (United States) specializing in medicine, cancer therapeutics, and oncology.

Top concepts

Publications per year

1996–2023

17

Publications

17

Economic burden of hospitalizations of Medicare beneficiaries with heart failure

Meredith L. Kilgore, Harshali Patel, Adrian Kielhorn et al. · Risk Management and Healthcare Policy · 2017 · 152 citations · Full text

UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drug

Adrian Kielhorn, Duncan Porter, Gavin Lewis · Current Medical Research and Opinion · 2008 · 58 citations

Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe

Joan H. Schiller, Dominic Tilden, M Aristides et al. · Lung Cancer · 2003 · 45 citations

, , +6

Neuromyelitis Optica Spectrum Disorder: Clinical Burden and Cost of Relapses and Disease-Related Care in US Clinical Practice

Minying Royston, Adrian Kielhorn, Derek Weycker et al. · Neurology and Therapy · 2021 · 42 citations · Full text

Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center

Adam P. Bress, Jordan B. King, Diana Brixner et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2016 · 37 citations

1–5 of 17